A cell study and patient-cohort analysis linked hypoxia-induced GP73 to HIF-1α-driven Warburg-like glycolysis in hepatocellular carcinoma, tying the pathway to tumor growth, invasion, and chemoembolization resistance markers. The work positions GP73 as an upstream regulator within hypoxic signaling that may help explain why tumors shift toward glycolytic metabolism and develop therapeutic resilience. The study also connects the findings to transarterial chemoembolization resistance features. While preclinical, the combined experimental and cohort approach points to possible stratification markers and therapeutic targets for hypoxia-adapted HCC subgroups.